C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: Epithelial and endothelial priming is required for C3a-induced eosinophil adhesion

Immunopharmacology

Volumn 46, Issue 3, 2000, Pages 209-222

  Jagels, Mark A ^a   Daffern, Pamela J ^a   Hugli, Tony E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cell to cell interactions; Complement; Eosinophils; Human; Neutrophils

Indexed keywords

ANAPHYLATOXIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BRONCHUS MUCOSA; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EOSINOPHIL; EPITHELIUM CELL; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL;

ANTIGENS, CD18; CELL ADHESION; CELLS, CULTURED; COMPLEMENT C3A; COMPLEMENT C5A; ENDOTHELIUM, VASCULAR; EOSINOPHILS; EPITHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; NEUTROPHILS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033976233     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00178-2     Document Type: Article

References (60)

1. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., Zeng Z., Su K., Jurewicz A.J., Hertzberg R.P., Bergsma D.J., Kumar C. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271:1996;20231-20234.
2. Anwar A.R.F., Walsh G.M., Cromwell O., Kay A.B., Wardlaw A.J. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology. 82:1994;222-228.
3. Beasley R., Roche W.R., Roberts J.A., Holgate S.T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:1989;806-817.
4. Bedard M., McClure C.D., Schiller N.L., Francoeur C., Cantin A., Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9:1993;455-462.
5. Belmont H.M., Buyon J., Giorno R., Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisted. Arthritis Rheum. 37:1994;376-383.
6. Bloemen P.G.M., van den Tweel M.C., Henricks P.A.J., Engels F., Wagenaar S.S., Rutten A.A.J.J.L., Nijkamp F.P. Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 9:1993;586-593.
7. Bohnsack J.F. CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6. Blood. 79:1992;1545-1552.
8. Bokisch V.A., Müller-Eberhard H.J. Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:1970;2427-2436.
9. Bozic C.R., Lu B., Hopken U.E., Gerard C., Gerard N.P. Neurogenic amplification of immune complex inflammation. Science. 273:1996;1722-1725.
10. Buyon J.P., Tamerius J., Belmont H.M., Abramson S.B. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum. 35:1992;1028-1037.
11. Christian-Ritter K.K., Hill L.D., Hoie E.B., Zach T.L. Effect of Interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells. Am. J. Pathol. 144:1994;171-176.
12. Coulpier M., Andreev S., Lemercier C., Dauchel H., Lees O., Fontaine M., Ripoche J. Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. Clin. Exp. Immunol. 101(1):1995;142-149.
13. Cox G., Gauldie J., Jordana M. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am. J. Respir. Cell Mol. Biol. 7:1992;507-513.
14. Daffern P.J., Pfeifer P.H., Ember J.A., Hugli T.E. C3a is a chemotaxin for human eosinophils but not for neutrophils: I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:1995;2119-2127.
15. Discipio R.G., Daffern P.J., Jagels M.A., Broide D.H., Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol. 162:1999;1127-1136.
16. Dohlman H.G., Thorner J., Caron M.G., Lefkowitz R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:1991;654-688.
17. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:1986;245-254.
18. Ebisawa M. Eosinophil transendothelial migration induced by cytokines: II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J. Immunol. 152:1994;4590-4596.
19. Ember, J.A., Jagels, M.A., Hugli, T.E., Characterization of complement anaphylatoxins and their biological responses. The human complement system in health and disease. In: Volanakis, J., Frank, M. (Eds.), Marcel Dekker, New York, 11 (1998) pp. 241-284.
20. Ember J.A., Johansen N.L., Hugli T.E. Designing synthetic superagonists of C3a anaphylatoxin. Biochemistry. 30:1991;3603-3612.
21. Erdei A., Pecht I. Complement peptides and mast cell triggering. Immunol. Lett. 54:1996;109-112.
22. Fernandez H., Henson P., Hugli T.E. A single scheme for C3a and C5a isolation and characterization of chemotatic behavior. [Abstract]. J. Immunol. 116:1976;1732.
23. Floreani A.A., Heires A.J., Welniak L.A., Miller-Lindholm A., Clark-Pierce L., Rennard S.I., Morgan E.L., Sanderson S.D. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 exposure to cigarette smoke. J. Immunol. 160:1999;5073-5081.
24. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Glovsky M.M., Eddy S.M., Ward P.A. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1994;1147-1155.
25. Gasque P., Singhrao S.K., Neal J.W., Wang P., Sayah S., Fontaine M., Morgan B.P. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J. Immunol. 160:1998;3543-3554.
26. Gibson P.G., Girgis-Gabardo A., Morris M.M., Mattoli S., Kay J.M., Dolovich J., Denburg J., Hargreave F.E. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax. 44:1989;693-699.
27. Hack C.E., Nuijens J.H., Felt-Bersma R.J.F., Schreuder W.O., Eerenberg-Belmer A.J.M., Paardekooper J., Bronsveld W., Thijs L.G. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with fatal outcome in sepsis. Am. J. Med. 86:1989;20-26.
28. Haviland D.L., McCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., Wetsel R.A. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154:1995;1861-1869.
29. Heideman M., Hugli T.E. Anaphylatoxin generation in multisystem organ failure. J. Trauma. 24:1984;1038-1043.
30. Herndon, D.N., Traber, D.L. Pulmonary failure and acute respiratory distress syndrome. Multiple organ failure. Pathophysiology and Basic Concepts of Therapy. In: Deitch, E.A. (Ed.), Thieme, New York, 1990, pp. 192-214.
31. Hopken U.E., Lu B., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature. 383:1996;86-89.
32. Hugli, T.E., Wingrove, J., Chen, Z., Polanowski, A., Matheson, N., Potempa, J., Travis, J., A role for complement in gingivitis: activation by a cysteine protease from porphyromonas gingivalis [Abstract]. University of Wales, Cardiff, Complement in Diseases 1991.
33. Iademarco M.F., Barks J.L., Dean D.C. Regulation of vascular cell adhesionmolecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J. Clin. Invest. 95:1995;264-271.
34. Jagels M.A., Daffern P.J., Zuraw B.L., Hugli T.E. Mechanisms and Regulation of PMN and eosinophil adherence to human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 21:1999;418-427.
35. Kishimoto T.K., Jutila M.A., Butcher E.C. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc. Natl. Acad. Sci. USA. 87:1990;2244-2248.
36. Kitayama J., Carr M.W., Roth S.J., Buccola J., Springer T.A. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils. J. Immunol. 158:1997;2340-2349.
37. Knol E.F., Tackey F., Tedder T.F., Klunk D.A., Bickel C.A., Sterbinsky S.A., Bochner B.S. Comparison of human eosinophil and neutrophil adhesion to endothelial cells under nonstatic conditions. J. Immunol. 153:1994;2161-2167.
38. Masuyama K., Samejima Y., Ishikawa T. Nasal tissue eosinophils in allergic rhinitis. Auris, Nasus, Larynx. 20:1993;205-213.
39. Meade P., Shoemaker W.C., Donnelly T.J., Abraham E., Jagels M.A., Cryer H.G., Hugli T.E., Bishop M.H., Wo C.C.J. Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J. Trauma. 36:1994;651-657.
40. Morita E., Schröder J.-M., Christophers E. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand. J. Immunol. 29:1989;709-716.
41. Mousli M., Hugli T.E., Landry Y., Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J. Immunol. 148:1992;2456-2461.
42. Moxley G., Ruddy S. Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patients. Arthritis Rheum. 30:1987;1097-1104.
43. Mulligan M.S., Schmid E., Till G.O., Friedl H.P., Hugli T.E., Johnson K.J., Ward P.A. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98:1996;503-512.
44. Nagata M. Endothelial cells upregulate eosinophil superoxide generation via VCAM-1 expression. Clin. Exp. Allergy. 29:1999;550-561.
45. 2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur. J. Biochem. 217:1993;289-294.
46. Patel K.D., McEver R.P. Comparison of tethering and rolling of eosinophils and neutrophils through selectins and P-selectin glycoprotein ligand-1. J. Immunol. 159:1997;4555-4565.
47. Rinderknecht H. Ultra-rapid fluorescent labelling of proteins. Nature (London). 193:1962;167-168.
48. Roglic A., Prossnitz E.R., Cavanagh S.L., Pan Z., Zou A., Ye R.D. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta. 1305:1996;39-43.
49. Schwartz L.B., Kawahara M.S., Hugli T.E., Vik D., Fearon D.T., Austen K.F. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J. Immunol. 130:1983;1891-1895.
50. Shoemaker W.C., Appel P.L., Czer S.C., Bland R., Schwartz S., Hopkins J.A. Pathogenesis of respiratory failure (ARDS) after hemorrhage and trauma. Crit. Care Med. 8:1980;504-512.
51. Sibelle Y., Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:1990;471-501.
52. Siciliano S.J., Rollins T.E., Springer M.S. Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states. J. Biol. Chem. 265:1990;19568-19574.
53. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
54. Sun J., Ember J.A., Chao T.-H., Fukuoka Y., Ye R.D., Hugli T.E. Identification of ligand effector binding sites in transmembrane regions of the human G-protein-coupled C3a receptor. Protein Science. 8:1999;2304-2311.
55. Sur S., Crotty T.B., Kephart G.M., Hyma B.A., Colby T.V., Reed C.E., Hunt L.W., Gleich G.J. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148:1993;713-719.
56. Takafuji S., Tadokoro K., Ito K., Dahinden C.A. Degranulation from human eosinophils stimulated with C3a and C5a. Int. Arch. Allergy Immunol. 104:1994;27-29.
57. Tonnesen M.G., Smedly L.A., Henson P.M. Neutrophil-endothelial cell interactions. J. Clin. Invest. 74:1984;1581-1592.
58. Walsh G.M., Mermod J.-J., Hartnell A., Kay A.B., Wardlaw A.J. Human eosinophil, but not neutrophil, adherence to IL-1- stimulated human umbilical vascular endothelial cells is alpha-4 beta-1 (very late antigen-4) dependent. J. Immunol. 146:1991;3419-3423.
59. Weber C., Kitayama J., Springer T.A. Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils. Proc. Natl. Acad. Sci. USA. 93:1996;10939-10944.
60. Wright S.D., Rao P.E., VanVoorhis W.C., Craigmyle L.S., Iida K., Talle M.A., Westbery E.F., Goldstein G., Silverstein S.C. Identification of the C3bi receptor of human monocytes and macrophages with monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 80:1983;5699-5703.